SCHEDULE: BlackRock Boosts Stake in Baxter International to 7.6%

BlackRock Portfolio Management LLC has disclosed an increased beneficial ownership of 7.6% in Baxter International Inc. common stock.

Summary

• BlackRock Portfolio Management LLC, acting on behalf of certain business units of BlackRock, Inc. and its subsidiaries and affiliates, reported beneficial ownership of Baxter International Inc.
• The aggregate beneficial ownership for these reporting units is 39,204,985 shares of common stock, representing 7.6% of the class.
• Several BlackRock subsidiaries, including Aperio Group, LLC, BlackRock (Luxembourg) S.A., and BlackRock Fund Advisors, are identified as entities that beneficially own 5% or greater of Baxter's outstanding shares.
• BlackRock Portfolio Management LLC holds sole voting power over 38,736,192 shares and sole dispositive power over 39,204,985 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously disclosed position.
• The investment is stated to be in the ordinary course of business and not for the purpose of changing or influencing control of Baxter International Inc.

Sentiment

Score: 7

Explanation: The filing is a routine disclosure of a significant passive institutional stake, which is generally a neutral to positive signal for the company, indicating confidence from a major asset manager. No negative information is presented.

Positives

• Increased institutional ownership by a major asset manager like BlackRock can signal confidence in the company's long-term prospects.
• The filing explicitly states the securities are held in the ordinary course of business and not for influencing control, indicating a passive investment.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing reflects a significant institutional investment in a major healthcare company, Baxter International, which operates in the medical products and services industry. Large passive stakes by asset managers like BlackRock are common across various industries, indicating a belief in the long-term value of the company within its sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant aggregate stake by BlackRock, through multiple subsidiaries, reinforces institutional confidence in Baxter International. This broad-based institutional interest may contribute to market stability and liquidity.

Key Dates

Keywords

Baxter International, BlackRock, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Healthcare, Medical Devices